$585 Million is the total value of Flagship Ventures Fund IV General Partner LLC's 5 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MCRB | New | SERES THERAPEUTICS INC | $368,438,000 | – | 12,682,876 | +100.0% | 62.99% | – |
| EDIT | New | EDITAS MEDICINE INC | $120,910,000 | – | 4,955,316 | +100.0% | 20.67% | – |
| SYRS | New | SYROS PHARMACEUTICALS INC | $87,241,000 | – | 4,806,656 | +100.0% | 14.92% | – |
| TTOO | New | T2 BIOSYSTEMS INC | $5,852,000 | – | 741,755 | +100.0% | 1.00% | – |
| EBIO | New | ELEVEN BIOTHERAPEUTICS INC | $2,464,000 | – | 1,466,417 | +100.0% | 0.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SERES THERAPEUTICS INC | 2 | Q2 2016 | 97.5% |
| T2 BIOSYSTEMS INC | 2 | Q2 2016 | 1.6% |
| ELEVEN BIOTHERAPEUTICS INC | 2 | Q2 2016 | 0.9% |
| EDITAS MEDICINE INC | 1 | Q2 2016 | 20.7% |
| SYROS PHARMACEUTICALS INC | 1 | Q2 2016 | 14.9% |
View Flagship Ventures Fund IV General Partner LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Moderna, Inc. | February 14, 2022 | 11,460,435 | 2.8% |
| Rubius Therapeutics, Inc. | February 14, 2022 | 5,000,000 | 5.6% |
| Syros Pharmaceuticals, Inc. | August 21, 2017 | 3,204,437 | 12.2% |
View Flagship Ventures Fund IV General Partner LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-14 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
| 4 | 2023-07-13 |
| 13F-NT | 2023-05-15 |
| 13F-NT | 2023-02-14 |
| 13F-NT | 2022-11-14 |
| 4 | 2022-10-17 |
| 13F-NT | 2022-08-15 |
| 4 | 2022-06-01 |
View Flagship Ventures Fund IV General Partner LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.